Stroke Prevention by Aggressive Reduction in Cholesterol Levels - SPARCL

Description:

The goal of the trial was to evaluate the effect of intensive lipid-lowering therapy with atorvastatin compared with placebo among patients with prior stroke or transient ischemic attack (TIA).